Aspire-Lakewood Holdings, Inc. (ASBP): Shareholders' Equity
-$6.38M
As of 2025-12-31
$11.76M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$6.38M | n/m | 2026-04-08, Balance as of period end |
| 2024-12-31 | -$1.54M | n/c | 2026-04-08, Balance as of period end |
| 2023-12-31 | -$322.1K | n/m | 2025-04-07, Balance as of period end |
| 2022-12-31 | -$9.94M | n/m | 2024-03-11, Balance as of period end |
| 2021-12-31 | -$475 | n/a | 2023-03-21, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Aspire-Lakewood Holdings, Inc. (ASBP) | 2025-12-31 | -$6.38M | n/m |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.15M | +4.4% |
| Genelux Corp (GNLX) | 2025-12-31 | $11.54M | -56.1% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $8.54M | +368.4% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | -$2.13M | n/m |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | -$10.26M | n/m |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | -$1.83M | n/m |
| Talphera, Inc. (TLPH) | 2025-12-31 | $17.04M | +112.9% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $12.61M | +196.1% |
Compare ASBP, TCRT, GNLX, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗